Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFE2L2 | Q16236 | 5/20 | 0.55 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.55 |
| ▸ | CA1 | P00915 | 2/20 | 0.55 |
| ▸ | CA2 | P00918 | 2/20 | 0.55 |
| ▸ | CA12 | O43570 | 1/20 | 0.55 |
| ▸ | CA4 | P22748 | 1/20 | 0.55 |
| ▸ | CA7 | P43166 | 1/20 | 0.55 |
| ▸ | CA9 | Q16790 | 1/20 | 0.55 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.55 |
| ▸ | TFEB | P19484 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.50 |
| ▸ | CYP1A1 | P04798 | 3/20 | 0.50 |
| ▸ | CYP1B1 | Q16678 | 3/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | GRIN2D | O15399 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13447647 | 0.84 | TLR2 (0.47) | NFE2L2TRPA1CA1CA2CA12 | |
| SCHEMBL8038506 | 0.83 | APP (0.47) | NFE2L2TRPA1CA1CA2CA12 | |
| SCHEMBL14909 | 0.81 | NFE2L2 (0.55) | NFE2L2TRPA1CA1CA2CA12 | |
| SCHEMBL29377009 | 0.81 | NFE2L2 (0.55) | NFE2L2TRPA1CA1CA2CA12 | |
| SCHEMBL1481334 | 0.81 | NFE2L2 (0.55) | NFE2L2TRPA1CA1CA2CA12 | |
| SCHEMBL1603719 | 0.80 | NFE2L2 (0.79) | NFE2L2TRPA1CA1CA2CA12 | |
| SCHEMBL4019329 | 0.80 | NFE2L2 (0.79) | NFE2L2TRPA1CA1CA2CA12 | |
| SCHEMBL7915752 | 0.80 | NFE2L2 (0.79) | NFE2L2TRPA1CA1CA2CA12 | |
| SCHEMBL240090 | 0.80 | CA1 (0.60) | NFE2L2TRPA1CA1CA2CA12 | |
| Benzene SCHEMBL28154477 | 0.79 | NFE2L2 (0.59) | NFE2L2TRPA1CA1CA2CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3689887-A1 | COMPOSITION AND LIGHT-EMITTING DEVICE USING SAME | Sumitomo Chemical Company Limited (JP) | 2020-08-05 | — | — | EP | disclosed |
| EP-2275428-B1 | Organometallic complex, and light-emitting element and light-emitting device using the same | SEMICONDUCTOR ENERGY LAB (JP) | 2019-02-20 | — | — | EP | disclosed |
| US-9653692-B2 | Light-emitting device and electronic appliance using the same | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2017-05-16 | — | — | US | disclosed |
| US-9653692-B2 | Light-emitting device and electronic appliance using the same | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2017-05-16 | — | — | US | disclosed |
| EP-1777229-B1 | Organometallic complex, and light-emitting element and light-emitting device using the same | SEMICONDUCTOR ENERGY LAB (JP) | 2016-09-07 | — | — | EP | disclosed |
| EP-1594003-B1 | Lithographic printing plate precursor and lithographic printing method | FUJIFILM CORP (JP) | 2016-06-15 | — | — | EP | disclosed |
| EP-1866321-B1 | ORGANOMETALLIC COMPLEX, AND LIGHT-EMITTING DEVICE AND ELECTRONIC APPLIANCE USING THE SAME | SEMICONDUCTOR ENERGY LAB (JP) | 2014-04-23 | — | — | EP | disclosed |
| EP-1869059-B1 | ORGANOMETALLIC COMPLEX, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE AND ELECTRONIC DEVICE USING THE ORGANOMETALLIC COMPLEX | SEMICONDUCTOR ENERGY LAB (JP) | 2014-04-23 | — | — | EP | disclosed |
| EP-2566302-A1 | Organometallic compounds and emission-shifting organic electrophosphorence | The Trustees of Princeton University (US) | 2013-03-06 | — | — | EP | disclosed |
| US-7834182-B2 | histamine H3 receptor antagonists; metabolic disorders, sleep disorders, cardiovascular disorders, alcoholism, drug addiction, memory disorders, Alzheimer's, Parkinson's disease; 2-(4-piperidinylpiperidinyl)pyrimidine compounds such as 2-[(4-piperidin-1-yl)piperidin-1-yl]-5-(3-pyridyl)pyrimidine | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2010-11-16 | — | — | US | disclosed |
| US-20090203710-A1 | Novel piperidine derivative | MSD K.K. (JP) | 2009-08-13 | — | — | US | disclosed |
| WO-2007032258-A1 | QUINOXALINE DERIVATIVE, AND LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, AND ELECTRONIC APPLIANCE USING THE SAME | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2007-03-22 | — | — | WO | disclosed |
| EP-0749974-B1 | PHOSPHONIC DIESTER DERIVATIVE | OTSUKA PHARMA CO LTD (JP) | 2001-06-27 | — | — | EP | disclosed |
| US-5798344-A | TREATING DIABETES, HYPERLIPIDEMIA | OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) | 1998-08-25 | — | — | US | disclosed |
| EP-0749974-A1 | PHOSPHONIC DIESTER DERIVATIVE | OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) | 1996-12-27 | — | — | EP | disclosed |
| EP-0593639-B1 | PYRROLIDINE AND THIAZOLIDINE DERIVATIVES, PREPARATION THEREOF AND DRUGS CONTAINING SAME | RHONE POULENC RORER SA (FR) | 1995-04-05 | — | — | EP | disclosed |
| EP-0593639-A1 | PYRROLIDINE AND THIAZOLIDINE DERIVATIVES, PREPARATION THEREOF AND DRUGS CONTAINING SAME. | RHONE POULENC RORER SA (FR) | 1994-04-27 | — | — | EP | disclosed |
| EP-0527069-A1 | Derivatives of pyrrolidine and thiazolidine, their preparation, and pharmaceutical compositions containing them | Aventis Pharma S.A. (FR) | 1993-02-10 | — | — | EP | disclosed |
| WO-1993001167-A1 | PYRROLIDINE AND THIAZOLIDINE DERIVATIVES, PREPARATION THEREOF AND DRUGS CONTAINING SAME | RHONE-POULENC RORER S.A. (FR) | 1993-01-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090203710-A1 | Novel piperidine derivative | HRH3, OPRM1, HRH4 | NFE2L2 2809/4885TRPA1 545/4885CA1 3574/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.